Pharming Group (PHAR) Earnings Date & Reports

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PHAR is expected to report earnings to rise 310.00% to 8 cents per share on November 05

Pharming Group PHAR Stock Earnings Reports

Q3'26

Est.

$0.08

Q2'26

Missed

by $0.04

Q1'26

Missed

by $0.08

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.10

The last earnings report on July 30 showed earnings per share of 1 cents, missing the estimate of 5 cents. With 17.06K shares outstanding, the current market capitalization sits at 716.24M.

View a ticker or compare two or three

PHAR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days